Skip to main content
LNA Santé logo

LNA Santé — Investor Relations & Filings

Ticker · LNA ISIN · FR0004170017 LEI · 969500FULTKJYIRIAT87 PA Human health and social work activities
Open in API
Filings indexed 557 across all filing types
Latest filing 2025-03-05 Declaration of Voting R…
Country FR France
Listing PA LNA

About LNA Santé

https://www.lna-sante.com/

LNA Santé is a healthcare operator focused on providing care for vulnerable individuals. The company manages and operates a diverse network of facilities, including medicalized nursing homes that offer long-term care and specialized support for neurodegenerative diseases like Alzheimer's and Parkinson's. Its portfolio also includes Medical Care and Rehabilitation (SMR) establishments for post-acute and follow-up care, surgical clinics, and mental health clinics. In addition to its residential and outpatient facilities, LNA Santé provides hospital-at-home (HAD) services, delivering complex medical care directly to patients' residences. The organization's integrated approach serves individuals facing temporary or permanent loss of autonomy, disabilities, or the need for specialized medical treatment and rehabilitation.

Recent filings

Filing Released Lang Actions
LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 28/02/2025
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" (Declaration under Article 223-16 of the General Regulation of the AMF) and provides the "Répartition de capital et des droits de vote attachés aux actions au 28/02/2025" (Distribution of capital and voting rights attached to shares as of 02/28/2025). This content specifically details the total number of shares and voting rights, which is a mandatory regulatory disclosure in France concerning share capital structure and voting power. This type of filing, dealing with capital structure and voting rights disclosure, aligns most closely with general regulatory announcements or specific capital structure updates. Given the options, it is a specific regulatory disclosure about capital and voting rights. While it relates to capital, it is not a financing activity (CAP) or a share issue (SHA), but rather a periodic disclosure of the current state of voting rights. This fits best under the general 'Regulatory Filings' (RNS) category as a specific, non-standard report, or potentially a very specific type of capital/shareholding disclosure. Since it is a formal declaration regarding the total number of voting rights, which is often a prerequisite for shareholder meetings or threshold crossings, and it doesn't fit perfectly into the other specific categories like DVA (which is about *results* of a vote), RNS is the most appropriate fallback for a mandatory, periodic regulatory disclosure of this nature that isn't a full financial report or a director's dealing.
2025-03-05 French
LNA SANTE : Q4 2024
Earnings Release Classification · 100% confidence The document is a press release from LNA Santé detailing their 2024 operating revenue and business performance. It provides key financial highlights, growth metrics, and operational data (occupancy rates, patient stays) for the fiscal year 2024. It is not a full annual report (10-K/AR) but rather an initial announcement of financial results. According to the filing definitions, an 'Earnings Release' (ER) is the initial announcement of quarterly/periodical financial results containing key highlights, which perfectly matches the content and structure of this document. FY 2024
2025-02-06 English
LNA SANTE : Chiffre d'affaires annuel 2024
Earnings Release Classification · 100% confidence The document is a press release titled 'Activité de l'année 2024' issued by LNA Santé. It provides a summary of the company's financial performance, specifically the revenue (CA Exploitation) for the full year 2024 and the fourth quarter, along with operational metrics like occupancy rates and patient numbers. It explicitly states that these are preliminary figures and that the full annual results will be published on March 26, 2025. As this is an initial announcement of periodic financial results (key highlights only) rather than the full annual report or a transcript, it is classified as an Earnings Release. FY 2024
2025-02-06 French
LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/01/2025
Regulatory Filings Classification · 95% confidence The document is a formal declaration of the total number of shares and voting rights as of January 31, 2025, pursuant to Article 223-16 of the AMF General Regulation. This type of disclosure is a standard regulatory requirement for listed companies in France to inform the market of their capital structure for the purpose of threshold crossing calculations. It does not represent a major shareholding notification (MRQ) by a specific investor, nor is it a share issue (SHA) or a report publication announcement (RPA). It fits best under the general regulatory filing category for mandatory disclosures.
2025-02-05 French
LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/12/2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" (Declaration under Article 223-16 of the General Regulation of the AMF) and provides the "Répartition de capital et des droits de vote attachés aux actions au 31/12/2024" (Distribution of capital and voting rights attached to shares as of 31/12/2024). This content specifically details the total number of shares, gross voting rights, and exercisable voting rights. This type of mandatory disclosure regarding capital structure and voting rights is a specific regulatory filing, but it does not fit perfectly into the defined categories like 10-K, ER, or DIV. It is a specific regulatory announcement concerning share structure and voting power, which is often reported via standard regulatory channels. Given the options, it is a specific regulatory disclosure. Since it is not a general announcement of a report (RPA) or a standard earnings/annual report, and it deals with capital structure and voting rights, it is closest to a specific regulatory filing. However, none of the codes perfectly match a mandatory capital/voting rights disclosure (like a French AMF filing). It is not a Director's Dealing (DIRS), Major Shareholding Notification (MRQ), or Share Issue (SHA). Since it is a formal, mandatory regulatory disclosure that doesn't fit the other specific categories, the most appropriate fallback is Regulatory Filings (RNS).
2025-01-09 French
LNA SANTE : Bilan semestriel du contrat de liquidité
Transaction in Own Shares Classification · 98% confidence The document is a short communication dated January 3, 2025, detailing the semi-annual balance sheet (bilan semestriel) of a liquidity contract (contrat de liquidité) between LNA Santé and ODDO BHF SCA, covering the period up to December 31, 2024. It reports the number of shares and cash held, as well as the transaction volumes (buys and sells) executed during the second half of the year. This type of regular reporting on share buyback/liquidity agreements is specifically covered by the 'Transaction in Own Shares' (POS) definition, which includes share repurchase programs. Since this is a specific report detailing the activity of such a contract, POS is the most appropriate classification over a general Regulatory Filing (RNS). The short length and specific content confirm it is the report itself, not an announcement of a report.
2025-01-03 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.